BiomX Inc.

BiomX Inc. announced an amendment to the promissory note related to its April 2026 acquisition of Zorronet Ltd. from Water.IO Ltd. The revised terms provide BiomX with additional flexibility for its remaining payments, including the issuance of 800,000 restricted shares to Water.IO for the extension and accrued interest. The final maturity date for the $1.25 million note has been extended to November 1, 2026, with an initial $250,000 payment followed by four equal monthly installments.

BiomX Inc. announced that its subsidiary, Zorronet Ltd., has formed a strategic collaboration with Samura s.r.o., a Czech company specializing in innovative technology distribution. This partnership will support projects across various sectors, including agriculture, infrastructure, and environmental monitoring, leveraging Zorronet's AI-powered software. The initial focus will be on developing AI-powered solutions for agricultural and urban pest management, and protecting critical transportation infrastructure, aiming to enhance efficiency, safety, and sustainability.

BiomX Inc. announced the cancellation of 1,013,637 restricted shares previously issued in connection with a convertible promissory note. This action was taken to regain compliance with NYSE American LLC's Section 712, which requires stockholder approval for certain transactions, including the company's acquisition of Dr. Frucht Systems Ltd. and a related line of credit. The company plans to seek stockholder approval for these transactions, though there is no assurance it will be obtained.

BiomX Inc. announced that its wholly owned subsidiary, Zorronet, has successfully transitioned its core operations to a new, advanced data center. This move is a critical step in Zorronet's infrastructure modernization, designed to enhance platform performance, scalability, and cost efficiency. The new facility will improve response times and increase capacity for handling complex security events, supporting the company's business expansion and enabling stronger real-time AI command-and-control solutions for its defense, homeland security, and critical infrastructure clients.

BiomX Inc.'s wholly owned subsidiary, BiomX Israel Defense and Security Ltd., has signed a non-binding letter of intent to acquire a 60% controlling interest in Tsoock Defense Technologies Ltd., an Israeli security infrastructure and systems integration company. The contemplated acquisition is for $10.4 million, with an initial payment of $300,000 and the remainder in quarterly installments, plus an option to acquire the remaining 40% for $9.2 million. This strategic move aims to integrate secure-site execution and systems integration capabilities into BiomX's defense, security, critical-infrastructure, and first-response portfolio, leveraging Tsoock's demonstrated growth and profitability in 2025.

BiomX Inc. announced that its wholly-owned subsidiary, Zorronet, has commenced the supply and installation of its AI and ML-powered detection and command-and-control systems on sections of the Israel Railways network. This follows a successful large-scale pilot that achieved a 98% success rate in deterring large animals from railway tracks and resulted in zero collisions. The initial phase covers four segments, with potential for further expansion as Israel Railways develops its infrastructure.

BiomX Inc. announced a change in its independent registered public accounting firm. On July 1, 2026, the Audit Committee and Board dismissed Kesselman & Kesselman (PwC) and simultaneously engaged Barzily & Co. as the new auditor for the fiscal year ending December 31, 2026. The company confirmed there were no disagreements or reportable events with PwC, although PwC's prior reports included a going concern explanatory paragraph.

BiomX Inc. has undergone a major strategic transformation, discontinuing its biopharmaceutical operations and pivoting to advanced defense, security, and critical infrastructure technologies. This pivot involved acquiring Zorronet Ltd. and a 60% stake in Dr. Frucht Systems Ltd. The company filed an S-1 registration statement for the resale of up to 7,163,000 shares of common stock by selling stockholders, including those issued in the recent acquisitions and shares from warrants/convertible notes. BiomX faces significant risks, including a going concern qualification and NYSE American listing non-compliance.

BiomX Inc. held its 2026 Annual Meeting of Stockholders on June 26, 2026, where shareholders approved all proposals. Ran Shaked was elected as a Class III director. Stockholders also approved an amendment to the 2026 Equity Incentive Plan, increasing the number of shares reserved for issuance by 5,460,000 to a total of 6,850,000 shares. An adjournment proposal was also approved but not utilized as the other proposals received sufficient votes.

BiomX Inc. announced that its majority-owned subsidiary, DFSL Ltd., will showcase its next-generation LADAR-based counter-drone and perimeter security solutions at ISC 2026. DFSL's proprietary Laser Radar (LADAR) platform, enhanced by on-sensor AI, provides real-time detection, classification, and tracking of UAVs and ground intruders with approximately 99% accuracy. This technology is designed to minimize false alarms and is already deployed in operational and pilot settings across Israel, Africa, and major U.S. transportation infrastructure, underscoring BiomX's strategic buildout of an integrated defense technology portfolio.